HCPCS Level II
J2356
Injection, tezepelumab-ekko, 1 mg
Codes near J2356
These sit next to J2356 in the CMS Level II file. All J codes
- J2350Injection, ocrelizumab, 1 mg
- J2351Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq
- J2353Injection, octreotide, depot form for intramuscular injection, 1 mg
- J2354Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
- J2355Injection, oprelvekin, 5 mg
- J2357Injection, omalizumab, 5 mg
- J2358Injection, olanzapine, long-acting, 1 mg
- J2359Injection, olanzapine, 0.5 mg
- J2360Injection, orphenadrine citrate, up to 60 mg
- J2361Injection, depemokimab-ulaa, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 55513-0112-01 | Tezspire | Amgen Inc | 210 |
| 55513-0123-01 | Tezspire | Amgen Inc | 210 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.